Physician profile
Vimal Ramjee
NPI 1437383676
$18,086.11
in general payments reported to CMS, 2019-2025
13 companies · $262 in 2025
The $262 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $513 · 2020: $167 · 2021: $29.19 · 2022: $4,735 · 2023: $1,974 · 2024: $10K · 2025: $262.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $11K · Food and Beverage: $1,216 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,025.00 |
| Food and Beverage | $1,216.38 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $400.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ge Healthcare | $9,676.31 | 2024 | |
| Viz.Ai, INC. | $4,668.44 | 2022 | |
| Heartflow, INC. | $2,904.75 | 2019-2025 | Ffrct |
| Boston Scientific Corporation | $517.31 | 2019-2025 | Watchman Access System, Watchman Flx |
| Abbott Laboratories | $167.48 | 2022-2024 | Mitraclip |
| Terumo Medical Corporation | $33.76 | 2023 | |
| Amgen INC. | $20.75 | 2024 | Repatha |
| Novo Nordisk INC | $19.00 | 2023 | Ozempic |
| Janssen Pharmaceuticals, INC | $18.78 | 2023 | Xarelto |
| Pfizer INC. | $18.60 | 2024 | |
| Astellas Pharma US INC | $17.21 | 2021 | |
| Baylis Medical Company INC | $11.98 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $11.74 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vimal Ramjee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.